Palisade Bio, Inc.: Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Data presented at the 2025 Crohn's and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure Company ...
gastroenterologyadvisor3h
JAK Inhibitors Effective in Older Adults With IBD
Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.
birmingham.ac.uk3h
Common antibiotic could treat inflammatory bowel disease, new study finds
Trial showed promising results for patients with IBD and autoimmune liver disease with 80% achieving clinical remission ...
Palisade Bio presents preclinical data of PALI-2108
Palisade Bio (PALI) announced the presentation of positive preclinical data from PALI-2108, an orally administered, colon-specific ...
I was going to the toilet 40 times a day, it nearly finished my career – FA Cup star opens up on horror bowel disease
JACK FITZWATER has revealed how he thought his football career was in jeopardy when he was forced to visit the toilet 40 times a day. The defender hopes to help League One club Exeter topple ...
Pharmabiz15h
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...